AccuVein to Showcase its True Center™ Technology and Sponsor Symposium at AVA 2022

AccuVein Inc., the global leader in Near-Infrared (NIR) vein visualization, announced today that it will be showcasing its innovative vein visualization device, the AccuVein® AV500, which features its patented “True Center™” technology during this year’s Association for Vascular Access (AVA2022) Annual Scientific Meeting, Friday, September 30 – Monday, October 3, at the Minneapolis Convention Center. AVA attendees will also be able to visit AccuVein’s booth #914 to learn more about its robust education/training program.

The AV500’s True Center™ technology allows clinicians to accurately view the center-line of a vein regardless of the distance. Unlike other vein visualization devices, the AV500 is permanently aligned and there is no need for device calibration prior to use. There are no other currently marketed NIR vein visualization devices that offer these distinct technological advancements.

Additionally, AccuVein will be sponsoring a Breakfast Symposium at AVA titled, Stop Going Blind and Get NIR Sighted, on Saturday, October 1, from 7- 8:30 am (ET) in room 101D. Leading experts in the peripheral IV access field who will lead the symposium discussion include, Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC, Gregory Schears, MD and Charlotte Hart, DNP(c), MSN, RN, CNE, VA-BC.

The key learning objectives for this session are:

• Discuss why peripheral IV catheter blind sticks are not best practice for venous access. • Describe how NIR vein visualization streamlines workflow and identifies more venous targets than can be palpated or seen with the naked eye.
• Show how NIR vein visualization helps reduce sticks, thus reducing patient pain and preserving vessel health.

To learn more about this session and to register, click here. Participants will earn 1.0 CE credit.

For more information on how NIR vein visualization technology can help eliminate blind sticks, please visit our booth.

“I am a strong advocate of eliminating the need for blind needle sticks in clinical practice,” said Charlotte Hart, VAT Supervisor. “We utilize AccuVein’s NIR vein visualization system every day in our practice and it has been a real ‘game changer’. We have implemented AccuVein into our PIV policy as a vessel assessment tool prior to every PIV placement and to assist in insertion. It has given us the ability to perform PIV access procedures more efficiently and confidently because of its precise accuracy. It has helped us gain back valuable nursing time and reduce our overall stress and anxiety. Equally important, we have seen a marked improvement in our clinical outcomes because we do not have to perform multiple needle stick attempts in the vast majority of our patients.”

Up to 90% of patients receive IV therapy at some point during their hospital stay, making it the most commonly performed invasive medical procedure in the U.S., and around the globe. Although it is routine, venipuncture can be technically challenging. When multiple venous access attempts are required, it is associated with increased patient morbidity, as well as increased utilization of staff and medical supplies.

“Starting a peripheral IV (PIV) catheter is the most common invasive procedure in health care. Our mission is to improve the standard of care as it pertains to peripheral venous assessment and access so placing a PIV becomes as safe, effective, efficient and cost effective as possible,” said Thomas Hopkins, Chief Medical Officer at AccuVein Inc. “We are extremely proud and committed to offering our healthcare heroes the latest advancement in NIR vein visualization technology. To further underscore our commitment to clinicians, we now provide customized training and education support to improve confidence and competence at the bedside, and help healthcare delivery teams with onboarding new staff,” added Hopkins.